Moderna’s vaccine targeting COVID-19 variants shows promise

A new version of Moderna’s COVID-19 vaccine appears to offer protection ‘against all variants of concern,’ according to preliminary results released by the company. It plans to offer a vaccine that will target both the original strain and the Omicron variant as early as this fall.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting